L. Harel et al., Raynaud's phenomenon as a manifestation of parvovirus B19 infection: Case reports and review of parvovirus B19 rheumatic and vasculitic syndromes, CLIN INF D, 30(3), 2000, pp. 500-503
Infection with human parvovirus B19 is manifested as erythema infectiosum,
transient aplastic crisis, or hydrops fetalis, Rheumatic manifestations inc
lude arthropathy and various vasculitic syndromes. Isolated Raynaud's pheno
menon due to parvovirus B19 has never been described. We report on 2 previo
usly healthy sisters with new-onset Raynaud's phenomenon accompanied by sev
ere generalized polyarthralgia, A full workup was negative, except serology
for parvovirus B19, which was positive. Air symptoms gradually subsided wi
thin 3-5 months, and no recurrence has been noted during the 3 years since
onset. We review all the studies in the English-language literature on parv
ovirus B19-induced rheumatic and vasculitic syndromes. We hypothesize that
the pathogenesis of Raynaud's phenomenon in our patients involved immune-me
diated endothelial damage leading to platelet activation and vasoconstricti
on. We recommend that in cases of unexplained Raynaud's phenomenon, serolog
y for parvovirus B19 be included in the evaluation.